LUNDBECK PHARMA A/S: Financial statements 2025
CVR: 56750215
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
LUNDBECK PHARMA A/S (CVR 56750215) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 18,887,000 and a net result of DKK 2,291,000 compared with DKK 1,820,000 the year before. That is an increase of 3% compared with the year before. The profit margin was 12.1%. Equity in the 2025 report amounted to DKK 3,378,000. The solvency ratio was 17.3%. The company had 18 employees in the financial year.
- Revenue
- DKK 18,887,000
- Gross Profit
- DKK 4,282,000
- Profit/Loss
- DKK 2,291,000
- Equity
- DKK 3,378,000
- Total Assets
- DKK 19,519,000
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 18.9M | 4.3M | 2.3M | 3.4M | 18 |
| 2024 | 18.3M | 1.9M | 1.8M | 3.5M | 20 |
| 2023 | 16M | 2.6M | 991K | 2.5M | - |
| 2022 | 17M | 2.3M | 982K | 2.3M | - |
| 2021 | 16.5M | 3.2M | 1.2M | 2.4M | 20 |
Official annual report
How creditworthy is LUNDBECK PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
LUNDBECK PHARMA A/S has won the tender "Amgros 2026 1.1060.a" issued by Amgros I/S worth 1,288,800,000 DKK.
As of April 1, 2025, Johannes Michael Leuchs has joined the board of directors of LUNDBECK PHARMA A/S.
As of April 1, 2025, Thomas Bo Bjørn Klee has left the board of directors of LUNDBECK PHARMA A/S.
As of April 1, 2025, Johannes Michael Leuchs is registered as adm. dir. of LUNDBECK PHARMA A/S.
As of April 1, 2025, Thomas Bo Bjørn Klee has stepped down as adm. dir. of LUNDBECK PHARMA A/S.
LUNDBECK PHARMA A/S has published its annual report for 2024. Revenue came to DKK 18,343,000, and the net result was DKK 1,820,000.
About LUNDBECK PHARMA A/S
LUNDBECK PHARMA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1958. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANS LUNDBECK A/S. The management consists of Søren Klein-Kristensen. The board consists of Michala Fischer-Hansen (chair), Søren Klein-Kristensen and Thomas Bo Bjørn Klee. The company is owned by H. LUNDBECK A/S. The company has 17 employees (2026). In 2025, the company reported revenue of DKK 18,887,000 and a net result of DKK 2,291,000 compared with DKK 1,820,000 the year before. Equity in the 2025 report amounted to DKK 3,378,000.